glp-1 and type 2 diabetes GLP-1-based therapies for diabetes: from single, dual triple agonists to endogenous production and L-cell differentiation | Diabetology & Metabolic Syndrome GLP-1 Receptor Agonists: A Game-Changer

The 24-year-old used to sleep 12 hours, wake up listless at noon and rely on DoorDash for most meals

Last reviewed: June 28, 2026 Last updated: June 28, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations

One mother reported transient gastrointestinal issues in her infant during semaglutide use, although these were not conclusively linked to the drug

Significant joint pain, persistent numbness or tingling, or notable changes in blood glucose warrant reassessment

Both manufacturers have agreed to participate in the model, and the following medications will be included: all formulations of Foundayo, Mounjaro, Ozempic, Rybelsus, and Wegovy, and the KwikPen formulation of Zepbound

These meds suppress appetiteif you dont get enough protein, your body may burn muscle